Matches in Nanopublications for { ?s ?p "[Here we demonstrate that about 20% of cases of LKS, CSWSS and electroclinically atypical rolandic epilepsy often associated with speech impairment can have a genetic origin sustained by de novo or inherited mutations in the GRIN2A gene (encoding the N-methyl-D-aspartate (NMDA) glutamate receptor ?2 subunit, GluN2A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP580485.RAl-ZcDfJyOD8fItJLiB0M6q1zfH46rv58rl-F7oz6sIE130_assertion description "[Here we demonstrate that about 20% of cases of LKS, CSWSS and electroclinically atypical rolandic epilepsy often associated with speech impairment can have a genetic origin sustained by de novo or inherited mutations in the GRIN2A gene (encoding the N-methyl-D-aspartate (NMDA) glutamate receptor ?2 subunit, GluN2A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580485.RAl-ZcDfJyOD8fItJLiB0M6q1zfH46rv58rl-F7oz6sIE130_provenance.
- assertion description "[Here we demonstrate that about 20% of cases of LKS, CSWSS and electroclinically atypical rolandic epilepsy often associated with speech impairment can have a genetic origin sustained by de novo or inherited mutations in the GRIN2A gene (encoding the N-methyl-D-aspartate (NMDA) glutamate receptor ?2 subunit, GluN2A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Here we demonstrate that about 20% of cases of LKS, CSWSS and electroclinically atypical rolandic epilepsy often associated with speech impairment can have a genetic origin sustained by de novo or inherited mutations in the GRIN2A gene (encoding the N-methyl-D-aspartate (NMDA) glutamate receptor ?2 subunit, GluN2A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Here we demonstrate that about 20% of cases of LKS, CSWSS and electroclinically atypical rolandic epilepsy often associated with speech impairment can have a genetic origin sustained by de novo or inherited mutations in the GRIN2A gene (encoding the N-methyl-D-aspartate (NMDA) glutamate receptor ?2 subunit, GluN2A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Here we demonstrate that about 20% of cases of LKS, CSWSS and electroclinically atypical rolandic epilepsy often associated with speech impairment can have a genetic origin sustained by de novo or inherited mutations in the GRIN2A gene (encoding the N-methyl-D-aspartate (NMDA) glutamate receptor ?2 subunit, GluN2A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP434529.RAgl-2OETmjToMx0WfWOJWqBT40fTo78ZESEnvPay5W5w130_assertion description "[Here we demonstrate that about 20% of cases of LKS, CSWSS and electroclinically atypical rolandic epilepsy often associated with speech impairment can have a genetic origin sustained by de novo or inherited mutations in the GRIN2A gene (encoding the N-methyl-D-aspartate (NMDA) glutamate receptor ?2 subunit, GluN2A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434529.RAgl-2OETmjToMx0WfWOJWqBT40fTo78ZESEnvPay5W5w130_provenance.
- NP1101117.RAsFjLPARIcQc_TE9WDFuzcYShjpYl8jnURRJhvaN9tJI130_assertion description "[Here we demonstrate that about 20% of cases of LKS, CSWSS and electroclinically atypical rolandic epilepsy often associated with speech impairment can have a genetic origin sustained by de novo or inherited mutations in the GRIN2A gene (encoding the N-methyl-D-aspartate (NMDA) glutamate receptor ?2 subunit, GluN2A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1101117.RAsFjLPARIcQc_TE9WDFuzcYShjpYl8jnURRJhvaN9tJI130_provenance.
- NP434532.RAyZs5WgISweph5S95S8Yoig8w5wrQaR5yR3RMdjqFmyc130_assertion description "[Here we demonstrate that about 20% of cases of LKS, CSWSS and electroclinically atypical rolandic epilepsy often associated with speech impairment can have a genetic origin sustained by de novo or inherited mutations in the GRIN2A gene (encoding the N-methyl-D-aspartate (NMDA) glutamate receptor ?2 subunit, GluN2A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434532.RAyZs5WgISweph5S95S8Yoig8w5wrQaR5yR3RMdjqFmyc130_provenance.
- NP1101115.RA2cAlCePHQYSk0J-nNe964cRUNG0nkI4xTnJgwcPnNco130_assertion description "[Here we demonstrate that about 20% of cases of LKS, CSWSS and electroclinically atypical rolandic epilepsy often associated with speech impairment can have a genetic origin sustained by de novo or inherited mutations in the GRIN2A gene (encoding the N-methyl-D-aspartate (NMDA) glutamate receptor ?2 subunit, GluN2A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1101115.RA2cAlCePHQYSk0J-nNe964cRUNG0nkI4xTnJgwcPnNco130_provenance.